Ahmed Moustafa

Dr. Ahmed Moustafa


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2025 in Nature Reviews Methods Primers
Verified
Journal Article
Closed access
PDF file
SLShaopeng Liu
Shaopeng Liu
JRJudith S. Rodriguez
Judith S. Rodriguez
VMViorel Munteanu
Viorel Munteanu
CRCynthia Ronkowski
Cynthia Ronkowski
NSNitesh Kumar Sharma
Nitesh Kumar Sharma
SMSerghei Mangul
Serghei Mangul

3 July 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SRSebastián A. Riquelme
Sebastián A. Riquelme
CLCarmen Lozano
Carmen Lozano
AMAhmed Moustafa
Ahmed Moustafa
KLKalle Liimatta
Kalle Liimatta
KTKira L. Tomlinson
Kira L. Tomlinson
APAlice Prince
Alice Prince
Excess succinate due to CFTR-PTEN dysfunction selects for Pseudomonas aeruginosa mutants adapted to the airway.

4 October 2024 in Science
Verified
Journal Article
Closed access
MAMohamad-Gabriel Alameh
Mohamad-Gabriel Alameh
ASAlexa Semon
Alexa Semon
NBNile U. Bayard
Nile U. Bayard
YPYi-Gen Pan
Yi-Gen Pan
GDGarima Dwivedi
Garima Dwivedi
JZJoseph P. Zackular
Joseph P. Zackular
Clostridioides difficile infection (CDI) is an urgent public health threat with limited preventative options. In this work, we developed a messenger RNA (mRNA)–lipid nanoparticle (LNP) vaccine targeting C. difficile toxins and virulence factors. This multivalent vaccine elicited robust and long-lived systemic and mucosal antigen-specific humoral and cellular immune responses across animal models, independent of changes to the intestinal microbiota. Vaccination protected mice from lethal CDI in both primary and recurrent infection models, and inclusion of non-toxin cellular and spore antigens improved decolonization of toxigenic C. difficile from the gastrointestinal tract. Our studies demonstrate mRNA-LNP vaccine technology as a promising platform for the development of novel C. difficile therapeutics with potential for limiting acute disease and promoting bacterial decolonization.

7 November 2018 in mBio
Verified
Journal Article
Open access
PDF file
MZMarta Zapotoczna
Marta Zapotoczna
GRGustavo P. Riboldi
Gustavo P. Riboldi
AMAhmed Moustafa
Ahmed Moustafa
EDElizabeth Dickson
Elizabeth Dickson
ANApurva Narechania
Apurva Narechania
JGJoan A. Geoghegan
Joan A. Geoghegan
Methicillin-resistant Staphylococcus aureus (MRSA) poses a substantial threat to human health worldwide and evolves rapidly by acquiring mobile genetic elements, such as plasmids. Here we investigate how the copB - mco copper hypertolerance operon carried on a mobile genetic element contributes to the virulence potential of clinical isolates of MRSA. Copper is a key component of innate immune bactericidal defenses. Here we show that copper hypertolerance genes enhance the survival of S. aureus inside primed macrophages and in whole human blood. The copB and mco genes are carried by clinical isolates responsible for invasive infections across Europe, and more broadly among three successful clonal lineages of S. aureus . Our findings show that a gain of copper hypertolerance genes increases the resistance of MRSA to phagocytic killing by host immune cells and imply that acquisition of this mobile genetic element can contribute to the success of MRSA.

7 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAhmed Moustafa
Ahmed Moustafa
TSTorsten Seemann
Torsten Seemann
SGSimon Gladman
Simon Gladman
BABen Adler
Ben Adler
MHMarina Harper
Marina Harper
MBMark D. Bennett
Mark D. Bennett
Pasteurella multocida is the primary causative agent of a range of economically important diseases in animals, including haemorrhagic septicaemia (HS), a rapidly fatal disease of ungulates. There is limited information available on the diversity of P. multocida strains that cause HS. Therefore, we determined draft genome sequences of ten disease-causing isolates and two vaccine strains and compared these genomes using a range of bioinformatic analyses. The draft genomes of the 12 HS strains were between 2,298,035 and 2,410,300 bp in length. Comparison of these genomes with the North American HS strain, M1404, and other available P. multocida genomes (Pm70, 3480, 36950 and HN06) identified a core set of 1,824 genes. A set of 96 genes was present in all HS isolates and vaccine strains examined in this study, but absent from Pm70, 3480, 36950 and HN06. Moreover, 59 genes were shared only by the Asian B:2 strains. In two Pakistani isolates, genes with high similarity to genes in the integrative and conjugative element, ICEPmu1 from strain 36950 were identified along with a range of other antimicrobial resistance genes. Phylogenetic analysis indicated that the HS strains formed clades based on their country of isolation. Future analysis of the 96 genes unique to the HS isolates will aid the identification of HS-specific virulence attributes and facilitate the development of disease-specific diagnostic tests.

12 August 2024 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
AUAndreacarola Urso
Andreacarola Urso
IMIan Monk
Ian Monk
YCYing-Tsun Cheng
Ying-Tsun Cheng
CPCamilla Predella
Camilla Predella
Tania Wong Fok LungTania Wong Fok Lung
Tania Wong Fok Lung
APAlice Prince
Alice Prince
Staphylococcus aureus is a pulmonary pathogen associated with substantial human morbidity and mortality. As vaccines targeting virulence determinants have failed to be protective in humans, other factors are likely involved in pathogenesis. Here we analysed transcriptomic responses of human clinical isolates of S. aureus from initial and chronic infections. We observed upregulated collagenase and proline transporter gene expression in chronic infection isolates. Metabolomics of bronchiolar lavage fluid and fibroblast infection, growth assays and analysis of bacterial mutant strains showed that airway fibroblasts produce collagen during S. aureus infection. Host-adapted bacteria upregulate collagenase, which degrades collagen and releases proline. S. aureus then imports proline, which fuels oxidative metabolism via the tricarboxylic acid cycle. Proline metabolism provides host-adapted S. aureus with a metabolic benefit enabling out-competition of non-adapted strains. These data suggest that clinical settings characterized by airway repair processes and fibrosis provide a milieu that promotes S. aureus adaptation and supports infection.